| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXNX | Common Stock | Options Exercise | $230K | +16.2K | +29.6% | $14.19* | 70.8K | Aug 10, 2022 | Direct | |
| transaction | AXNX | Common Stock | Options Exercise | $214K | +8.3K | +11.72% | $25.82 | 79.1K | Aug 10, 2022 | Direct | |
| transaction | AXNX | Common Stock | Options Exercise | $133K | +9.37K | +11.84% | $14.19* | 88.5K | Aug 10, 2022 | Direct | |
| transaction | AXNX | Common Stock | Sale | -$1.7M | -24.5K | -27.66% | $69.35 | 64K | Aug 10, 2022 | Direct | F1, F2 |
| transaction | AXNX | Common Stock | Sale | -$657K | -9.37K | -14.64% | $70.12 | 54.7K | Aug 10, 2022 | Direct | F1, F3 |
| holding | AXNX | Common Stock | 4K | Aug 10, 2022 | By Spouse |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXNX | Stock Options (Right to buy) | Options Exercise | $0 | -25.5K | -69.87% | $0.00 | 11K | Aug 10, 2022 | Common Stock | 25.5K | $14.19 | Direct | F4 |
| transaction | AXNX | Stock Options (Right to buy) | Options Exercise | $0 | -8.3K | -45.45% | $0.00 | 9.96K | Aug 10, 2022 | Common Stock | 8.3K | $25.82 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. |
| F2 | This transaction was executed in multiple trades at prices ranging from $68.98 to $69.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $70.00 to $70.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on January 30th, 2020, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of January 30th, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. |
| F5 | The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 12, 2023, provided the reporting person remains in continuous service on each vesting date. |